Article Versions Notes

Carvalho RF, do Canto LM, Cury SS, Frøstrup Hansen T, Jensen LH, Rogatto SR. Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer. Cancers. 2021; 13(21):5492. https://doi.org/10.3390/cancers13215492

Carvalho, Robson Francisco, Luisa Matos do Canto, Sarah Santiloni Cury, Torben Frøstrup Hansen, Lars Henrik Jensen, and Silvia Regina Rogatto. 2021. "Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer" Cancers 13, no. 21: 5492. https://doi.org/10.3390/cancers13215492

Carvalho, R. F., do Canto, L. M., Cury, S. S., Frøstrup Hansen, T., Jensen, L. H., & Rogatto, S. R. (2021). Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer. Cancers, 13(21), 5492. https://doi.org/10.3390/cancers13215492